Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 6

The association of papillary thyroid cancer with microcalcification in thyroid nodules with indeterminate cytology based on fine-needle aspiration biopsy

Pages
1719–1723
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Surgery might be considered primarily for patients harboring nodule(s) with IC accompanied by microcalcification due to increased risk of PTC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Microcalcifications are generally accepted as highly specific for thyroid malignancy, especially for papillary thyroid carcinoma (PTC).
📊
Key Findings & Data:Materials and methods: Patients who underwent thyroidectomy between January 2010 and 2013 were included in the study.
💡
Conclusion & Impact:Conclusion: Surgery might be considered primarily for patients harboring nodule(s) with IC accompanied by microcalcification due to increased risk of PTC.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Microcalcifications are generally accepted as highly specific for thyroid malignancy, especially for papillary thyroid carcinoma (PTC). The aim of this study was to determine the significance of microcalcification within nodules that were classified as being of indeterminate cytology (IC) according to fine-needle aspiration biopsy. Materials and methods: Patients who underwent thyroidectomy between January 2010 and 2013 were included in the study. Nodules identified as atypia/follicular lesion of undetermined significance , follicular neoplasm/suspicious for follicular neoplasm , orsuspicious for malignancy were categorized as IC. Patients were subcategorized depending on the presence of microcalcification (Group 1) or its absence (Group 2). The relationship between microcalcification and PTC was evaluated in the IC group retrospectively. Results: Indeterminate cytology was detected in 135 (28.5%) of 473 patients. Microcalcification was detected in 27 (20%) of 135 nodules and classified as Group 1, while the remaining 108 (80%) patients were classified as Group 2. According to the final pathology results, PTC was diagnosed in 13 of 27 (48.1%) patients in Group 1 and 29 of 108 (26.8%) patients in Group 2. A statistically significant relation between microcalcification and malignancy was determined in the IC group (P < 0.05). Conclusion: Surgery might be considered primarily for patients harboring nodule(s) with IC accompanied by microcalcification due to increased risk of PTC.

🔖

Cite This Article

EREN, T., ALİMOĞLU, O., BAYRAKTAR, B., ANILIR, E., YİĞİTBAŞI, R., ÖZEMİR, İ. A., ORHUN, K., SAĞIROĞLU, J., CEYRAN, A. B. (2022). The association of papillary thyroid cancer with microcalcification in thyroid nodules with indeterminate cytology based on fine-needle aspiration biopsy. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 6, 1719–1723. https://ajindex.com/articles/610791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Brander AE, Viikinkoski VP, Nickels JI, Kivisaari LM. Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 2000; 215: 801-806
  2. Bai Y, Zhou G, Nakamura M, Ozaki T, Mori I, Taniguchi E, Miyauchi A, Ito Y, Kakudo K. Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol 2009; 22: 887-894
  3. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005; 237: 794-800
  4. Seiberling KA, Dutra JC, Grant T, Bajramovic S. Role of intrathyroidal calcifications detected on ultrasound as a marker of malignancy. Laryngoscope 2004; 114: 1753-1757
  5. Cibas ES, Syed ZA. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132: 658-665
  6. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel JS, Mazzaferri LE, McIver B, Pacini F, Schlumberger M et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167-1214
  7. Bongiovanni M, Spitale A, Faquin WC, Mazzuchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 2012; 56: 333-339
  8. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012; 367: 705-715
  9. LiVolsi VA, Mazzaferri EL, Schneider AB. Papillary carcinoma. In: Delellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of Endocrine Organs. Lyon, France: International Agency for Research on Cancer: Lyon, France; 2004. pp. 57-66
  10. Kakudo K, Tang W, Ito Y, Mori I, Makamura Y, Miyauchi A. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 2004; 57: 1041-1046
  11. Bai Y, Kakudo K, Li Y, Liu Z, Ozaki T, Ito Y, Kihara M, Miyauchi A. Subclassification of nonsolid- type papillary thyroid carcinoma identification of high-risk group in common type. Cancer Sci 2008; 99: 1908-1915